Squarepoint Ops LLC Biomarin Pharmaceutical Inc Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Squarepoint Ops LLC holds 204,526 shares of BMRN stock, worth $13.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

204,526

Previous 31,600 547.23%

Holding current value

$13.6 Million

Previous $2.6 Million 452.71%

% of portfolio

0.02%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$69.02 - $93.84 $6.96 Million - $9.46 Million	100,841 Added 97.26%	204,526 $14.4 Million
Q2 2024 Aug 14, 2024	SELL	$74.43 - $92.22 $56.4 Million - $69.9 Million	-757,532 Reduced 87.96%	103,685 $8.54 Million
Q1 2024 May 15, 2024	BUY	$83.81 - $99.0 $48.8 Million - $57.7 Million	582,506 Added 209.0%	861,217 $75.2 Million
Q4 2023 Feb 14, 2024	SELL	$76.22 - $98.51 $2.94 Million - $3.8 Million	-38,580 Reduced 12.16%	278,711 $26.9 Million
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $12.6 Million - $14.6 Million	145,932 Added 85.16%	317,291 $27.5 Million
Q1 2023 May 15, 2023	SELL	$87.74 - $117.27 $331,130 - $442,576	-3,774 Reduced 2.15%	171,359 $16.7 Million
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $12.3 Million - $16.5 Million	151,541 Added 642.34%	175,133 $18.1 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $1.94 Million - $2.29 Million	23,592 New	23,592 $2 Million
Q2 2022 Aug 15, 2022	SELL	$71.48 - $86.85 $15.6 Million - $19 Million	-218,758 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$74.28 - $92.69 $2.88 Million - $3.59 Million	-38,713 Reduced 15.04%	218,758 $16.9 Million
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $4.31 Million - $5.5 Million	60,156 Added 30.49%	257,471 $22.7 Million
Q3 2021 Nov 15, 2021	BUY	$74.77 - $85.47 $8.12 Million - $9.28 Million	108,567 Added 122.33%	197,315 $15.3 Million
Q2 2021 Aug 16, 2021	SELL	$75.51 - $84.79 $2.82 Million - $3.16 Million	-37,305 Reduced 29.59%	88,748 $7.41 Million
Q1 2021 May 17, 2021	BUY	$74.73 - $90.69 $5.1 Million - $6.19 Million	68,303 Added 118.27%	126,053 $9.52 Million
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $2.32 Million - $2.88 Million	31,884 Added 123.27%	57,750 $5.06 Million
Q3 2020 Nov 16, 2020	SELL	$71.87 - $131.03 $3.14 Million - $5.73 Million	-43,736 Reduced 62.84%	25,866 $1.97 Million
Q2 2020 Aug 14, 2020	SELL	$79.55 - $124.22 $4.1 Million - $6.41 Million	-51,583 Reduced 42.57%	69,602 $8.59 Million
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $17.2 Million - $23.4 Million	-241,492 Reduced 66.59%	121,185 $10.2 Million
Q4 2019 Feb 14, 2020	BUY	$64.27 - $86.37 $19.4 Million - $26 Million	301,244 Added 490.36%	362,677 $30.7 Million
Q3 2019 Nov 14, 2019	SELL	$67.4 - $85.11 $3.92 Million - $4.95 Million	-58,184 Reduced 48.64%	61,433 $4.14 Million
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $1.09 Million - $1.28 Million	13,582 Added 12.81%	119,617 $10.2 Million
Q1 2019 May 15, 2019	BUY	$84.2 - $98.62 $8.57 Million - $10 Million	101,802 Added 2404.96%	106,035 $9.42 Million
Q4 2018 Feb 14, 2019	BUY	$80.14 - $106.07 $339,232 - $448,994	4,233 New	4,233 $360,000
Q4 2017 Feb 14, 2018	SELL	$80.76 - $95.13 $4.48 Million - $5.28 Million	-55,529 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $4.48 Million - $5.27 Million	55,529	55,529 $5.17 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.3B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Biomarin Pharmaceutical Inc Transaction History